About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
NVCR - NovoCure Limited| Previous Close | $108.98 | Open | $107.26 |
| Volume | 6.73M | Market Cap | 11.017B |
| Yield | Last Dividend |
| Top Analyst Upgrades and Downgrades: Bos... | 09/17/20 |
| No summary available. | |
| The Daily Biotech Pulse: Moderna Inks 2 ... | 09/17/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Ar... | |
| The Daily Biotech Pulse: Moderna Expands... | 09/16/20 |
| Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Avidity Biosciences Inc (NASDAQ: RNA ) Beigene Ltd (NASDAQ: BGNE ) Bicycle Therapeut... | |
| NovoCure (NVCR): Why this medtech firm m... | 09/14/20 |
| Even as COVID-19 is wreaking havoc across the world, cancer continues to kill about 10 million people per year, and the quest for the most effective c... | |
| Novocure Announces Expansion of Its Exec... | 08/13/20 |
| ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure announced an expansion of its Executive Leadership Team, effective Sept. 1, 2020. | |
| Novocure Reports Second Quarter 2020 Fin... | 07/30/20 |
| ST. HELIER, Jersey--(BUSINESS WIRE)---- $NVCR--Novocure reported financial results for the quarter ended June 30, 2020, and provided a company update. | |
| Novocure Announces Recipients of 2nd Ann... | 07/28/20 |
| ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure announced today the recipients of the AACR-Novocure Grants for Tumor Treating Fields Research program. | |
| Novocure initiates mid-stage study of el... | 07/22/20 |
| Novocure (NVCR +5.6%) has enrolled first patient in its Phase 2 pivotal (EF-33) trial of Tumor Treating Fields delivered utilizing high-intensity arra... | |
| Novocure teams up with Merck in lung can... | 07/15/20 |
| Novocure (NASDAQ:NVCR) will collaborate with Merck (NYSE:MRK) on a Phase 2 pilot study evaluating the concomitant use of Tumor Treating Fields and Key... | |
| Novocure to Report Second Quarter 2020 F... | 07/01/20 |
| ST. HELIER, Jersey--(BUSINESS WIRE)---- $NVCR #earnings--Novocure will report financial results for the second quarter 2020 on Thursday, July 30, 2020... | |
| Novocure Announces Launch of MyLink??? t... | 06/02/20 |
| ST. HELIER, Jersey--(BUSINESS WIRE)--A new tool will enable patients to download their Optune usage data without the need for an in-person visit by a ... | |
| NovoCure (NVCR) Lags Q1 Earnings and Rev... | 04/30/20 |
| NovoCure (NVCR) delivered earnings and revenue surprises of -20.00% and -2.19%, respectively, for the quarter ended March 2020. Do the numbers hold cl... | |
| Novocure Reports First Quarter 2020 Fina... | 04/30/20 |
| ST. HELIER, Jersey--(BUSINESS WIRE)---- $NVCR--Novocure reported financial results for the first quarter of 2020 and provided a company update. | |
| Novocure Announces Presentation of EF-19... | 04/27/20 |
| ST. HELIER, Jersey--(BUSINESS WIRE)-- #btsm--Novocure announced that EF-19 post-approval registry trial data will be presented at the AACR 2020 Virtua... | |
| NovoCure (NVCR) Earnings Expected to Gro... | 04/23/20 |
| NovoCure (NVCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with ... | |
| Novocure Reports Fourth Quarter and Full... | 02/27/20 |
| ST. HELIER, Jersey--(BUSINESS WIRE)---- $NVCR--Novocure today reported fourth quarter and full year 2019 financial results and provided a company upda... | |
| NovoCure (NVCR) Earnings Expected to Gro... | 02/20/20 |
| NovoCure (NVCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with ... | |
| The Daily Biotech Pulse: Roche Reports P... | 01/23/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 22) ... | |
| Novocure Announces Fourth Quarter and Fu... | 01/13/20 |
| ST. HELIER, Jersey--(BUSINESS WIRE)-- #JPM20--Novocure reported operating statistics and preliminary, unaudited net revenues and cash balances for the... | |
| Novocure Reports Third Quarter 2019 Fina... | 10/31/19 |
| ST. HELIER, Jersey--(BUSINESS WIRE)---- $NVCR #earnings--Novocure reported today financial results from third quarter 2019 and provided a company upda... | |
| Will NovoCure (NVCR) Report Negative Ear... | 10/24/19 |
| NovoCure (NVCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with ... | |
| The Daily Biotech Pulse: ViiV's Long-Act... | 08/22/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 21) ... | |
| The Daily Biotech Pulse: Roche Snags Dou... | 08/16/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 15) ... | |
| Novocure's Charts Are as Bullish As They... | 08/14/19 |
| Novocure Ltd.'s (NVCR) charts are as bullish as charts get, so here's a strategy for investing in the oncology company that has had a strong run that ... | |
| NovoCure Looks Due for a Technical Corre... | 08/07/19 |
| Let's look at the charts and indicators in addition to following the fundamentals???.NVCR | |
| The Daily Biotech Pulse: Roche-Spark Dea... | 07/31/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 30) ... | |
| The Daily Biotech Pulse: European Cheer ... | 07/30/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 29) ... | |
| NovoCure Limited (NVCR) Shares March Hig... | 07/26/19 |
| As of late, it has definitely been a great time to be an investor in NovoCure Limited (NVCR). | |
| The Daily Biotech Pulse: Obseva Gets The... | 07/26/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 25) ... | |
| NovoCure (NVCR) Reports Q2 Loss, Tops Re... | 07/25/19 |
| NovoCure (NVCR) delivered earnings and revenue surprises of 85.71% and 6.38%, respectively, for the quarter ended June 2019. Do the numbers hold clues... | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Burdeshaw Investing | Matthew Burdeshaw | 55.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
